he spent a year as a research chemist (and was technically an 'illegal alien') at Lakeside Laboratories in Milwaukee, Wisconsin. Working in his own time during evenings at the lab, he conducted research that figured in a new way of synthesizing steroids.
He started work at Harvard University in Cambridge, Massachusetts, in 1946. There, Stork became a seminal figure in the emergence of stereocontrolled synthesis, the science of precisely connecting molecular fragments into distinct 3D arrays. In partnership with one of his students, Albert Burgstahler, he performed one of the earliest examples of the stereocontrolled synthesis of a natural product -the compound cantharidin. This set the standard for future work in the field.
Also during this time, Stork proposed a cascading set of reactions that converted long linear molecules into products that have many molecular rings (polycycles), later called the Stork-Eschenmoser hypothesis. This provided the conceptual basis for biomimetic synthesis, and for work by Johnson and others on making polycycles, including human hormones and many therapeutic agents.
In 1953, Stork joined the faculty at Columbia University. There he published his first studies on enamine alkylations, a general way to make carbon-carbon bonds. This served as a foundation for synthesis techniques using certain metalcontaining reactive species (called metallo-enamines), and for the selective generation of compounds called ketone enolates, highly useful intermediates for bond formation. Later, he pioneered the use of yet other reactive intermediates for building complex molecules, including free-radical-based methods for carboncarbon bond formation.
Stork was fascinated by reaction mechanisms and intermediates, and had an uncanny ability to see that special bond or arrangement of atoms in a complex target that was a key to its construction. Make that bond, and the molecule would almost seem to self-assemble.
He chose his targets well, picking molecules that both posed synthetic challenges and had interesting biological activity. Over the years, he targeted and made sex hormones, steroids, hormone-like prostaglandins and anticancer agents. Some 60 years after setting his sights on the compound, in 2001 he and his co-workers published the first stereoselective total synthesis of quinine (G. Stork et al. J. Am. Chem. Soc. 123, 3239-3242; 2001) .
His last paper, published just weeks before his death, reported studies towards the synthesis of an agent called germine, which can be used to control blood pressure -a compound that at least 15 students had worked on between 1979 and 2000 (G. Stork et al. Org. Lett. 19, 5150-5153; 2017) . In 2010, Gilbert and his second wife, Ayako Yamashita, declared that finishing this synthesis would be a good retirement project. According to a colleague at Columbia, the two completed it "as a labor of love -a gift to each other and to all of Professor Stork's students".
Stork's mastery inspired his co-workers and all who followed in his steps. One of his most enduring contributions is his influence on many generations of chemists and how they think about synthesis. Chemist who revolutionized molecular synthesis. 
